You have read all your free articles, to continue reading subscribe to read the rest of this content.
The capital injection will be used for further clinical development of the company's drug candidate. Modulfin is currently in phase I/II and is developed to increase the efficacy and decrease side effects during cancer treatments. It is based on a derivative of the B vitamine folic acid. At the mAlready…
Medow has successfully landed its largest sales agreement to date – which is also the largest business deal that a SmiLe company has made during its time in the incubator program. “We are thrilled that we, with help from especially SmiLe and HSN Consultancy, successfully attracted the interesAlready a subscriber…
Valo Therapeutics has successfully raised 11 million EUR in an oversubscribed Pre-IPO funding round. The Pre-IPO fund included participation from existing investors, Freeman Road, and new investors, including ASX-listed MMJ Group Holdings. The total raised to date is now over Euro 22 million (aroAlready a subscriber Login You have read…
Aerocrine’s NIOX MINO device for measuring FeNO receives approval by Health Canada. 2712Already a subscriber Login You have read all your free articles, to continue reading subscribe to read the rest of this content.…
